Patients will be randomized into 1 of 3 treatment groups. Medications are provided free of charge . This study is offered to patients who are experiencing anemia as a result of HIV disease or medications. This medication is FDA-approved. The study will evaluate whether patients experience an improvement in Quality of Life while receiving the medication.
Medication is provided free of charge .
An open-label extension phase of the evaluation of Sustiva in combination with d4T and 3TC in treatment na ve patients. This project studies the natural history of HIV in women. The Clinical Investigations Department at Whitman-Walker Clinic is currently working with staff at NIH to facilitate the enrollment of eligible patients for several NIH studies. The protocols will be conducted at the National Institutes of Health in collaboration with WWC research staff. All eligible patients are welcome to participate.